Related Experiment Video
Updated: Jun 8, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Infections in polymyositis and dermatomyositis: analysis of 192 cases
I-Jung Chen1, Wen-Pin Tsai, Yeong-Jian Jan Wu
1Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, 5 Fu-Shin Street, Kuei-Shan (333), Tao-Yuan, Taiwan, Republic of China. gout@adm.cgmh.org.tw.
Objectives:
To estimate the incidence, characteristics and predictors of infections in patients with PM and DM.
Methods:
The medical records of 192 PM/DM patients followed up in a tertiary teaching medical centre from 1999 to 2008 were retrospectively reviewed.
Results:
Seventy-six episodes of major infection, defined as infections requiring>1 week of treatment with anti-microbial agents, occurred in 53 (27.6%) patients, and 15 (7.8%) patients had two or more episodes. The incidence rate of major infections was 11.1 episodes per 100 patient-years in PM/DM patients. Aspiration pneumonia [n (%)=16 (21.1)] was the leading cause of major infections, followed by opportunistic infection [n (%)=14 (18.4)]. A variety of pathogens were isolated, mainly including Staphylococcus aureus, Klebsiella, Escherichia coli, Salmonella and Mycobacterium. Overall patient survival rates were 85.0% at 1 year, 78.0% at 5 years and 78.0% at 10 years. However, after one episode of major infection, survival rates decreased to 84.7% at 30 days and 68.3% at 1 year. Multivariate analysis indicated that independent predictors of major infection were age>45 years at PM/DM onset [odds ratio (OR) 5.26; 95% CI 2.01, 13.77; P=0.001], presence of arthritis/arthalgia (OR 2.59; 95% CI 1.12, 6.02; P=0.027), co-present interstitial lung disease (OR 7.24; 95% CI 2.67, 19.65; P<0.001), current use of AZA (OR 6.07; 95% CI 2.39, 15.42; P<0.001) or IVIG (OR 6.33; 95% CI 1.50, 26.77; P=0.012).
Conclusions:
This study underlines the high frequency of major infections in PM/DM, which is significantly detrimental to patient survival rates. Close follow-up of PM/DM patients with risk factors for developing major infections is mandatory.
Insights
Major infections are common in polymyositis (PM) and dermatomyositis (DM) patients, significantly reducing survival rates. Close monitoring of PM/DM patients with identified risk factors is essential for better outcomes.
Area of Science:
- Rheumatology
- Infectious Diseases
- Clinical Medicine
Background:
- Polymyositis (PM) and dermatomyositis (DM) are idiopathic inflammatory myopathies.
- Infections pose a significant threat to patients with PM and DM.
Purpose of the Study:
- To determine the incidence, characteristics, and predictors of major infections in patients with PM and DM.
- To assess the impact of infections on patient survival.
Main Methods:
- Retrospective review of medical records of 192 PM/DM patients from 1999 to 2008.
- Analysis of infection episodes, pathogens, and patient survival rates.
- Multivariate analysis to identify independent predictors of major infection.
Main Results:
- The incidence of major infections was 11.1 episodes per 100 patient-years.
- Aspiration pneumonia and opportunistic infections were the leading causes.
- Age over 45, arthritis/arthralgia, interstitial lung disease, and use of azathioprine (AZA) or intravenous immunoglobulin (IVIG) were significant predictors of infection.
- Major infections decreased patient survival rates.
Conclusions:
- PM/DM patients experience a high frequency of major infections.
- Infections are detrimental to patient survival.
- Regular monitoring of PM/DM patients with risk factors for infection is crucial.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Myocarditis I: Introduction
Poliomyelitis
Myocarditis III: Medical Management
Fungal Phylum Microsporidia